TreeWAS – Variant ID: rs12899811

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R39.1 Other difficulties with micturition	0.020	0.980	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.018	0.982	0.000
M48.0 Spinal stenosis	0.018	0.982	0.000
M48.09 Spinal stenosis (Site unspecified)	0.016	0.984	0.000
M48.04 Spinal stenosis (Thoracic region)	0.016	0.984	0.000
M48.06 Spinal stenosis (Lumbar region)	0.014	0.986	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.014	0.986	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.013	0.987	0.000
M48.03 Spinal stenosis (Cervicothoracic region)	0.013	0.987	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.013	0.987	0.000
M48.02 Spinal stenosis (Cervical region)	0.013	0.987	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.012	0.987	0.000
S22.40 Multiple fractures of ribs (closed)	0.000	0.990	0.010
S22.20 Fracture of sternum (closed)	0.000	0.990	0.010
S22.4 Multiple fractures of ribs	0.000	0.990	0.010
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.990	0.010
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.990	0.010
S22.2 Fracture of sternum	0.000	0.990	0.010
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.990	0.010
S22.0 Fracture of thoracic vertebra	0.000	0.990	0.010
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.991	0.009
I60 Subarachnoid haemorrhage	0.000	0.991	0.009
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.991	0.009
M48 Other spondylopathies	0.009	0.991	0.000
S22.1 Multiple fractures of thoracic spine	0.000	0.991	0.009
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.000	0.992	0.008
I60.8 Other subarachnoid haemorrhage	0.000	0.992	0.008
M48.9 Spondylopathy, unspecified	0.008	0.992	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.000	0.992	0.008
S22.10 Multiple fractures of thoracic spine (closed)	0.000	0.992	0.008
S22.41 Multiple fractures of ribs (open)	0.000	0.993	0.007
S22.9 Fracture of bony thorax, part unspecified	0.000	0.993	0.007
S22.8 Fracture of other parts of bony thorax	0.000	0.993	0.007
S22.21 Fracture of sternum (open)	0.000	0.993	0.007
S22.01 Fracture of thoracic vertebra (open)	0.000	0.993	0.007
S22.5 Flail chest	0.000	0.993	0.007
I60.5 Subarachnoid haemorrhage from vertebral artery	0.000	0.993	0.007
M48.96 Spondylopathy, unspecified (Lumbar region)	0.006	0.993	0.000
M48.92 Spondylopathy, unspecified (Cervical region)	0.006	0.993	0.000
M48.4 Fatigue fracture of vertebra	0.006	0.994	0.000
M48.3 Traumatic spondylopathy	0.006	0.994	0.000
M48.2 Kissing spine	0.006	0.994	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.006	0.994	0.000
S22.11 Multiple fractures of thoracic spine (open)	0.000	0.994	0.006
I60.4 Subarachnoid haemorrhage from basilar artery	0.000	0.994	0.006
M48.8 Other specified spondylopathies	0.006	0.994	0.000
Z11.2 Special screening examination for other bacterial diseases	0.000	0.994	0.006
K90.9 Intestinal malabsorption, unspecified	0.006	0.994	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.994	0.006
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.000	0.994	0.006
M48.99 Spondylopathy, unspecified (Site unspecified)	0.006	0.994	0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.006	0.994	0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.006	0.994	0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.006	0.994	0.000
M48.94 Spondylopathy, unspecified (Thoracic region)	0.006	0.994	0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.006	0.994	0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.006	0.994	0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.006	0.994	0.000
S22.81 Fracture of other parts of bony thorax (open)	0.000	0.994	0.005
S22.80 Fracture of other parts of bony thorax (closed)	0.000	0.994	0.005
S22.91 Fracture of bony thorax, part unspecified (open)	0.000	0.994	0.005
S22.90 Fracture of bony thorax, part unspecified (closed)	0.000	0.994	0.005
S22.51 Flail chest (open)	0.000	0.995	0.005
M48.5 Collapsed vertebra, not elsewhere classified	0.005	0.995	0.000
S22.3 Fracture of rib	0.000	0.995	0.005
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.005	0.995	0.000
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)	0.005	0.995	0.000
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)	0.005	0.995	0.000
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)	0.005	0.995	0.000
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)	0.005	0.995	0.000
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)	0.005	0.995	0.000
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)	0.005	0.995	0.000
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)	0.005	0.995	0.000
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)	0.005	0.995	0.000
M48.29 Kissing spine (Site unspecified)	0.005	0.995	0.000
M48.28 Kissing spine (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M48.27 Kissing spine (Lumbosacral region)	0.005	0.995	0.000
M48.26 Kissing spine (Lumbar region)	0.005	0.995	0.000
M48.25 Kissing spine (Thoracolumbar region)	0.005	0.995	0.000
M48.24 Kissing spine (Thoracic region)	0.005	0.995	0.000
M48.23 Kissing spine (Cervicothoracic region)	0.005	0.995	0.000
M48.22 Kissing spine (Cervical region)	0.005	0.995	0.000
M48.21 Kissing spine (Occipito-atlanto-axial region)	0.005	0.995	0.000
M48.20 Kissing spine (Multiple sites in spine)	0.005	0.995	0.000
M48.39 Traumatic spondylopathy (Site unspecified)	0.005	0.995	0.000
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M48.37 Traumatic spondylopathy (Lumbosacral region)	0.005	0.995	0.000
M48.36 Traumatic spondylopathy (Lumbar region)	0.005	0.995	0.000
M48.35 Traumatic spondylopathy (Thoracolumbar region)	0.005	0.995	0.000
M48.34 Traumatic spondylopathy (Thoracic region)	0.005	0.995	0.000
M48.33 Traumatic spondylopathy (Cervicothoracic region)	0.005	0.995	0.000
M48.32 Traumatic spondylopathy (Cervical region)	0.005	0.995	0.000
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)	0.005	0.995	0.000
M48.30 Traumatic spondylopathy (Multiple sites in spine)	0.005	0.995	0.000
M48.49 Fatigue fracture of vertebra (Site unspecified)	0.005	0.995	0.000
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M48.47 Fatigue fracture of vertebra (Lumbosacral region)	0.005	0.995	0.000
M48.46 Fatigue fracture of vertebra (Lumbar region)	0.005	0.995	0.000
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)	0.005	0.995	0.000
M48.44 Fatigue fracture of vertebra (Thoracic region)	0.005	0.995	0.000
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)	0.005	0.995	0.000
M48.42 Fatigue fracture of vertebra (Cervical region)	0.005	0.995	0.000
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)	0.005	0.995	0.000
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)	0.005	0.995	0.000
M48.89 Other specified spondylopathies (Site unspecified)	0.005	0.995	0.000
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M48.87 Other specified spondylopathies (Lumbosacral region)	0.005	0.995	0.000
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.005	0.995	0.000
M48.84 Other specified spondylopathies (Thoracic region)	0.005	0.995	0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.005	0.995	0.000
M48.82 Other specified spondylopathies (Cervical region)	0.005	0.995	0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.005	0.995	0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.005	0.995	0.000
M48.86 Other specified spondylopathies (Lumbar region)	0.004	0.995	0.000
S22.50 Flail chest (closed)	0.000	0.995	0.004
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.995	0.005
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
R39 Other symptoms and signs involving the urinary system	0.004	0.996	0.000
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.004	0.996	0.000
L73.9 Follicular disorder, unspecified	0.000	0.996	0.004
S20-S29 Injuries to the thorax	0.000	0.996	0.004
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.996	0.004
I84.4 External haemorrhoids with other complications	0.004	0.996	0.000
S21 Open wound of thorax	0.000	0.996	0.004
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.004	0.996	0.000
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.004	0.996	0.000
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.004	0.996	0.000
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.004	0.996	0.000
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.004	0.996	0.000
S22.31 Fracture of rib (open)	0.000	0.996	0.004
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.000	0.996	0.004
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.004	0.996	0.000
H16.0 Corneal ulcer	0.000	0.996	0.004
G80.1 Spastic diplegia	0.004	0.996	0.000
S21.2 Open wound of back wall of thorax	0.000	0.996	0.004
Z95.4 Presence of other heart-valve replacement	0.004	0.996	0.000
N21.0 Calculus in bladder	0.000	0.996	0.004
R39.0 Extravasation of urine	0.004	0.996	0.000
G80.8 Other infantile cerebral palsy	0.004	0.996	0.000
G80 Infantile cerebral palsy	0.004	0.996	0.000
D13.1 Stomach	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
G80.0 Spastic cerebral palsy	0.003	0.996	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.003	0.997	0.000
S20 Superficial injury of thorax	0.000	0.997	0.003
T14.0 Superficial injury of unspecified body region	0.003	0.997	0.000
T14 Injury of unspecified body region	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
S21.1 Open wound of front wall of thorax	0.000	0.997	0.003
R39.2 Extrarenal uraemia	0.003	0.997	0.000
T14.1 Open wound of unspecified body region	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
S21.9 Open wound of thorax, part unspecified	0.000	0.997	0.003
T14.9 Injury, unspecified	0.003	0.997	0.000
H26.1 Traumatic cataract	0.000	0.997	0.003
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.000	0.997	0.003
S26 Injury of heart	0.000	0.997	0.003
S25 Injury of blood vessels of thorax	0.000	0.997	0.003
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.000	0.997	0.003
I49.0 Ventricular fibrillation and flutter	0.000	0.997	0.003
T14.6 Injury of tendons and muscles of unspecified body region	0.003	0.997	0.000
G80.9 Infantile cerebral palsy, unspecified	0.003	0.997	0.000
S21.8 Open wound of other parts of thorax	0.000	0.997	0.003
S21.7 Multiple open wounds of thoracic wall	0.000	0.997	0.003
S21.0 Open wound of breast	0.000	0.997	0.003
S20.4 Other superficial injuries of back wall of thorax	0.000	0.997	0.003
S24 Injury of nerves and spinal cord at thorax level	0.000	0.997	0.003
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.997	0.003
G80.4 Ataxic cerebral palsy	0.003	0.997	0.000
G80.3 Dyskinetic cerebral palsy	0.003	0.997	0.000
S20.0 Contusion of breast	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
S20.7 Multiple superficial injuries of thorax	0.000	0.997	0.003
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.997	0.003
T14.2 Fracture of unspecified body region	0.003	0.997	0.000
T14.8 Other injuries of unspecified body region	0.003	0.997	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.003	0.997	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.003	0.997	0.000
T14.4 Injury of nerve(s) of unspecified body region	0.003	0.997	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.003	0.997	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.997	0.003
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.002	0.997	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
G80.2 Infantile hemiplegia	0.003	0.997	0.000
S20.3 Other superficial injuries of front wall of thorax	0.000	0.997	0.003
S20.1 Other and unspecified superficial injuries of breast	0.000	0.997	0.003
T39.0 Salicylates	0.003	0.997	0.000
S20.2 Contusion of thorax	0.000	0.997	0.003
M47.86 Other spondylosis (Lumbar region)	0.003	0.997	0.000
S23.5 Sprain and strain of other and unspecified parts of thorax	0.000	0.997	0.002
S23.4 Sprain and strain of ribs and sternum	0.000	0.997	0.002
S23.3 Sprain and strain of thoracic spine	0.000	0.997	0.002
S23.2 Dislocation of other and unspecified parts of thorax	0.000	0.997	0.002
S23.1 Dislocation of thoracic vertebra	0.000	0.997	0.002
S23.0 Traumatic rupture of thoracic intervertebral disk	0.000	0.997	0.002
S25.9 Injury of unspecified blood vessel of thorax	0.000	0.997	0.002
S25.8 Injury of other blood vessels of thorax	0.000	0.997	0.002
S25.7 Injury of multiple blood vessels of thorax	0.000	0.997	0.002
S25.5 Injury of intercostal blood vessels	0.000	0.997	0.002
S25.4 Injury of pulmonary blood vessels	0.000	0.997	0.002
S25.3 Injury of innominate or subclavian vein	0.000	0.997	0.002
S25.2 Injury of superior vena cava	0.000	0.997	0.002
S25.1 Injury of innominate or subclavian artery	0.000	0.997	0.002
S25.0 Injury of thoracic aorta	0.000	0.997	0.002
S26.9 Injury of heart, unspecified	0.000	0.997	0.002
S26.8 Other injuries of heart	0.000	0.997	0.002
S26.0 Injury of heart with haemopericardium	0.000	0.997	0.002
S28.1 Traumatic amputation of part of thorax	0.000	0.997	0.002
S28.0 Crushed chest	0.000	0.997	0.002
N08.5 Glomerular disorders in systemic connective tissue disorders	0.003	0.997	0.000
D72.8 Other specified disorders of white blood cells	0.003	0.997	0.000
S29 Other and unspecified injuries of thorax	0.000	0.997	0.002
S24.6 Injury of unspecified nerve of thorax	0.000	0.997	0.002
S24.5 Injury of other nerves of thorax	0.000	0.997	0.002
S24.4 Injury of thoracic sympathetic nerves	0.000	0.997	0.002
S24.3 Injury of peripheral nerves of thorax	0.000	0.997	0.002
S24.2 Injury of nerve root of thoracic spine	0.000	0.997	0.002
S24.0 Concussion and oedema of thoracic spinal cord	0.000	0.997	0.002
C79 Secondary malignant neoplasm of other sites	0.000	0.997	0.003
F31 Bipolar affective disorder	0.000	0.998	0.002
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.998	0.002
H16 Keratitis	0.000	0.998	0.002
M25.96 Joint disorder, unspecified (Lower leg)	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
C79.2 Secondary malignant neoplasm of skin	0.000	0.998	0.002
H16.1 Other superficial keratitis without conjunctivitis	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
S24.1 Other and unspecified injuries of thoracic spinal cord	0.000	0.998	0.002
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
S27 Injury of other and unspecified intrathoracic organs	0.000	0.998	0.002
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.998	0.002
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.998	0.002
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.998	0.002
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.998	0.002
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.998	0.002
L81.4 Other melanin hyperpigmentation	0.000	0.998	0.002
T14.21 Fracture of unspecified body region (open)	0.002	0.998	0.000
T14.20 Fracture of unspecified body region (closed)	0.002	0.998	0.000
H16.2 Keratoconjunctivitis	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
S26.01 Injury of heart with haemopericardium (with open wound into thoracic cavity)	0.000	0.998	0.002
S26.00 Injury of heart with haemopericardium (without open wound into thoracic cavity)	0.000	0.998	0.002
S26.81 Other injuries of heart (with open wound into thoracic cavity)	0.000	0.998	0.002
S26.80 Other injuries of heart (without open wound into thoracic cavity)	0.000	0.998	0.002
S26.91 Injury of heart, unspecified (with open wound into thoracic cavity)	0.000	0.998	0.002
S26.90 Injury of heart, unspecified (without open wound into thoracic cavity)	0.000	0.998	0.002
S29.7 Multiple injuries of thorax	0.000	0.998	0.002
H16.8 Other keratitis	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
F31.9 Bipolar affective disorder, unspecified	0.000	0.998	0.002
H16.4 Corneal neovascularisation	0.000	0.998	0.002
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.998	0.002
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
C79.6 Secondary malignant neoplasm of ovary	0.000	0.998	0.002
S27.8 Injury of other specified intrathoracic organs	0.000	0.998	0.002
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
R49.8 Other and unspecified voice disturbances	0.002	0.998	0.000
F31.7 Bipolar affective disorder, currently in remission	0.000	0.998	0.002
I69.3 Sequelae of cerebral infarction	0.000	0.998	0.002
M95.0 Acquired deformity of nose	0.000	0.998	0.002
Q23.1 Congenital insufficiency of aortic valve	0.000	0.998	0.002
H16.3 Interstitial and deep keratitis	0.000	0.998	0.002
N08.3 Glomerular disorders in diabetes mellitus	0.002	0.998	0.000
S27.1 Traumatic haemothorax	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
S27.9 Injury of unspecified intrathoracic organ	0.000	0.998	0.002
S27.7 Multiple injuries of intrathoracic organs	0.000	0.998	0.002
S27.6 Injury of pleura	0.000	0.998	0.002
S27.5 Injury of thoracic trachea	0.000	0.998	0.002
S27.4 Injury of bronchus	0.000	0.998	0.002
S29.8 Other specified injuries of thorax	0.000	0.998	0.002
Z71.9 Counselling, unspecified	0.002	0.998	0.000
M51.9 Intervertebral disk disorder, unspecified	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
S29.9 Unspecified injury of thorax	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
J39.2 Other diseases of pharynx	0.000	0.998	0.002
K51.2 Ulcerative (chronic) proctitis	0.002	0.998	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.998	0.002
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.000	0.998	0.002
S27.80 Injury of other specified intrathoracic organs (without open wound into thoracic cavity)	0.000	0.998	0.002
R29.6 Tendency to fall, not elsewhere classified	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
T51.0 Ethanol	0.002	0.998	0.000
F31.8 Other bipolar affective disorders	0.000	0.998	0.002
M51.4 Schmorl's nodes	0.002	0.998	0.000
S36.10 Injury of liver or gallbladder (without open wound into cavity)	0.002	0.998	0.000
H16.9 Keratitis, unspecified	0.000	0.998	0.002
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
N21 Calculus of lower urinary tract	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
S29.0 Injury of muscle and tendon at thorax level	0.000	0.998	0.001
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
S27.81 Injury of other specified intrathoracic organs (with open wound into thoracic cavity)	0.000	0.998	0.002
N08.8 Glomerular disorders in other diseases classified elsewhere	0.002	0.998	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.002	0.998	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.002	0.998	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
S27.3 Other injuries of lung	0.000	0.998	0.002
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)	0.000	0.998	0.001
N21.1 Calculus in urethra	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
S27.41 Injury of bronchus (with open wound into thoracic cavity)	0.000	0.998	0.001
S27.40 Injury of bronchus (without open wound into thoracic cavity)	0.000	0.998	0.001
S27.51 Injury of thoracic trachea (with open wound into thoracic cavity)	0.000	0.998	0.001
S27.50 Injury of thoracic trachea (without open wound into thoracic cavity)	0.000	0.998	0.001
S27.61 Injury of pleura (with open wound into thoracic cavity)	0.000	0.998	0.001
S27.60 Injury of pleura (without open wound into thoracic cavity)	0.000	0.998	0.001
S27.71 Multiple injuries of intrathoracic organs (with open wound into thoracic cavity)	0.000	0.998	0.001
S27.70 Multiple injuries of intrathoracic organs (without open wound into thoracic cavity)	0.000	0.998	0.001
S27.91 Injury of unspecified intrathoracic organ (with open wound into thoracic cavity)	0.000	0.998	0.001
S27.90 Injury of unspecified intrathoracic organ (without open wound into thoracic cavity)	0.000	0.998	0.001
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.998	0.002
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.998	0.002
S27.2 Traumatic heamopneumothorax	0.000	0.998	0.001
T36.0 Penicillins	0.002	0.998	0.000
T47.4 Other laxatives	0.001	0.998	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.000	0.998	0.002
J35.0 Chronic tonsillitis	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
T47.7 Emetics	0.001	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.001	0.998	0.000
T47.5 Digestants	0.001	0.998	0.000
T47.3 Saline and osmotic laxatives	0.001	0.998	0.000
T47.2 Stimulant laxatives	0.001	0.998	0.000
M47.82 Other spondylosis (Cervical region)	0.002	0.998	0.000
C95.9 Leukaemia, unspecified	0.002	0.998	0.000
G95.1 Vascular myelopathies	0.000	0.998	0.002
J30.1 Allergic rhinitis due to pollen	0.002	0.998	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.001	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.001	0.998	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.998	0.002
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
H46 Optic neuritis	0.002	0.998	0.000
S22.30 Fracture of rib (closed)	0.000	0.998	0.001
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.998	0.001
H93.8 Other specified disorders of ear	0.002	0.998	0.000
M72.2 Plantar fascial fibromatosis	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
T36.8 Other systemic antibiotics	0.001	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
T36.6 Rifamycins	0.001	0.998	0.000
T36.5 Aminoglycosides	0.001	0.998	0.000
T36.4 Tetracyclines	0.001	0.998	0.000
T36.3 Macrolides	0.001	0.998	0.000
T36.2 Chloramphenicol group	0.001	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.998	0.000
M51 Other intervertebral disk disorders	0.002	0.998	0.000
C71.2 Temporal lobe	0.000	0.998	0.002
N21.9 Calculus of lower urinary tract, unspecified	0.000	0.998	0.001
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.998	0.000
L73.2 Hidradenitis suppurativa	0.001	0.998	0.000
M50.0 Cervical disk disorder with myelopathy	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000
T37.5 Antiviral drugs	0.001	0.998	0.000
T37.4 Anthelminthics	0.001	0.998	0.000
T37.3 Other antiprotozoal drugs	0.001	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
T37.1 Antimycobacterial drugs	0.001	0.998	0.000
T37.0 Sulphonamides	0.001	0.998	0.000
Z83.5 Family history of eye and ear disorders	0.000	0.998	0.002
O34.1 Maternal care for tumour of corpus uteri	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.998	0.000
T41.5 Therapeutic gases	0.001	0.998	0.000
T41.4 Anaesthetic, unspecified	0.001	0.998	0.000
T41.3 Local anaesthetics	0.001	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.001	0.998	0.000
T41.1 Intravenous anaesthetics	0.001	0.998	0.000
T41.0 Inhaled anaesthetics	0.001	0.998	0.000
T49.9 Topical agent, unspecified	0.001	0.998	0.000
T49.8 Other topical agents	0.001	0.998	0.000
T49.7 Dental drugs, topically applied	0.001	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.001	0.998	0.000
T49.2 Local astringents and local detergents	0.001	0.998	0.000
T49.1 Antipruritics	0.001	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.998	0.000
Z97.5 Presence of (intra-uterine) contraceptive device	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
S27.31 Other injuries of lung (with open wound into thoracic cavity)	0.000	0.998	0.001
N87.0 Mild cervical dysplasia	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.998	0.000
T48.5 Anti-common-cold drugs	0.001	0.998	0.000
T48.4 Expectorants	0.001	0.998	0.000
T48.3 Antitussives	0.001	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.001	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.998	0.000
T48.0 Oxytocic drugs	0.001	0.998	0.000
M72.29 Plantar fascial fibromatosis-Site unspec	0.001	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.001	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.999	0.001
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.001	0.999	0.000
N21.8 Other lower urinary tract calculus	0.000	0.999	0.001
Q23.0 Congenital stenosis of aortic valve	0.000	0.999	0.001
T48.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.000	0.999	0.001
Y52.1 Calcium-channel blockers	0.001	0.999	0.000
Z00.6 Examination for normal comparison and control in clinical research programme	0.001	0.999	0.000
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)	0.000	0.999	0.001
G82.1 Spastic paraplegia	0.001	0.999	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.999	0.001
G83.9 Paralytic syndrome, unspecified	0.001	0.999	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
M25.78 Osteophyte (Other)	0.001	0.999	0.000
M72.28 Plantar fascial fibromatosis-Other	0.001	0.999	0.000
M72.26 Plantar fascial fibromatosis-Lower Leg	0.001	0.999	0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.001	0.999	0.000
M72.24 Plantar fascial fibromatosis-Hand	0.001	0.999	0.000
M72.23 Plantar fascial fibromatosis-Forearm	0.001	0.999	0.000
M72.22 Plantar fascial fibromatosis-Upper arm	0.001	0.999	0.000
M72.21 Plantar fascial fibromatosis-Shldr region	0.001	0.999	0.000
M72.20 Plantar fascial fibromatosis-Mult sites	0.001	0.999	0.000
H52.3 Anisometropia and aniseikonia	0.000	0.999	0.001
M51.3 Other specified intervertebral disk degeneration	0.001	0.999	0.000
M51.1 Lumbar and other intervertebral disk disorders with radiculopathy	0.001	0.999	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.001	0.999	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
M21.67 Other acquired deformities of ankle and foot-Ankle/foot	0.001	0.999	0.000
Y52.7 Peripheral vasodilators	0.001	0.999	0.000
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.999	0.001
E14.9 Without complications	0.001	0.999	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.001	0.999	0.000
O21.1 Hyperemesis gravidarum with metabolic disturbance	0.001	0.999	0.000
T38.9 Other and unspecified hormone antagonists	0.001	0.999	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
T38.7 Androgens and anabolic congeners	0.001	0.999	0.000
T38.5 Other oestrogens and progestogens	0.001	0.999	0.000
T38.4 Oral contraceptives	0.001	0.999	0.000
T38.2 Antithyroid drugs	0.001	0.999	0.000
Z80.8 Family history of malignant neoplasm of other organs or systems	0.000	0.999	0.001
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.000	0.999	0.001
M51.8 Other specified intervertebral disk disorders	0.001	0.999	0.000
S27.0 Traumatic pneumothorax	0.000	0.999	0.001
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.001	0.999	0.000
C18.7 Sigmoid colon	0.000	0.999	0.001
T38.1 Thyroid hormones and substitutes	0.001	0.999	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
Z44.3 Fitting and adjustment of external breast prosthesis	0.000	0.999	0.001
Z89.4 Acquired absence of foot and ankle	0.001	0.999	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.001	0.999	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.999	0.001
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.999	0.001
H34.2 Other retinal artery occlusions	0.000	0.999	0.001
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.999	0.001
O21.0 Mild hyperemesis gravidarum	0.001	0.999	0.000
M21.26 Flexion deformity (Lower leg)	0.000	0.999	0.001
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.001	0.999	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.999	0.001
N02.2 Diffuse membranous glomerulonephritis	0.001	0.999	0.000
Q23 Congenital malformations of aortic and mitral valves	0.000	0.999	0.001
M94.88 Other specified disorders of cartilage (Other)	0.001	0.999	0.000
N04.9 Unspecified	0.001	0.999	0.000
R29.1 Meningismus	0.000	0.999	0.001
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.001	0.999	0.000
M51.19 Lumbar and other intervertebral disc disorders with radiculopathy; site unspecified	0.001	0.999	0.000
M51.16 Intervertebral disc disorders w radiculopathy, lumbar region	0.001	0.999	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.001	0.999	0.000
Y00.9 Unspecified place	0.000	0.999	0.001
M10.90 Gout, unspecified (Multiple sites)	0.001	0.999	0.000
M51.37 Other intervertebral disc degeneration, lumbosacral region	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations